In this study, we employed a potent USP10/13 deubiquitinating activity antagonist, spautin‐1, to investigate the effect of targeting USP10/USP13 as an anti‐melanoma treatment and found that melanoma cell proliferation was significantly suppressed by spautin‐1‐induced ROS‐mediated DNA damage. The gene discussed is USP13; the disease is melanoma.